π₯ Can a Blood Pressure Pill Boost Metabolism? AI Slashes Seizure False Alarms by 80%
Published about 2 hours agoΒ β’Β 1 min read
Health Mania #001 β Can Scientists Regrow Knees? The $1.2B Obesity-Drug Showdown
Lab-grown knees? A $1.2B obesity deal? Cancer shockwaves? Press START for five stories.
|
|
|
1UP β’ ISSUE #001 β’ OCT 15, 2026
|
|
|
THE FIRST BELL // BREAKING HEALTH ROUNDUP
CAN WE REGROW KNEES?
THE $1.2B DRUG SHOWDOWN!
Cancer shocks, biotech billions and new medical contenders enter the ring.
|
|
|
|
|
5 STORIES β’ 2-MINUTE ROUND β’ PRESS START
|
WELCOME TO THE RING!
Five scorching health headlines. Surprising science. Serious deals.
Zero snooze-fests. LET'S RUMBLE!
|
|
MAIN EVENT // OCT 15
CAN SCIENTISTS REALLY REGROW A KNEE?
Researchers are racing to rebuild damaged knees with living
3D-printed tissue and engineered cells. One experimental design has
withstood realistic mechanical testing. Human benefit remains
unproven β but the fight against arthritis just got interesting.
READ STORY >>
|
|
|
GLOBAL HEADLINE // OCT 15
POPE LEO RETURNS TO WORK AFTER LUNG CANCER SURGERY
Doctors say the 71-year-old pontiff is recovering as expected after
surgery to remove a lung tumor. The next big question is what
pathology results mean for further treatment.
READ STORY >>
|
|
|
BILLION-DOLLAR SHOWDOWN // OCT 13
AI ENTERS THE OBESITY-DRUG ARMS RACE
Zealand Pharma and Generate Biomedicines struck a collaboration
worth up to $1.2 billion to develop AI-designed protein therapies
for obesity. That is potential deal value, not cash paid upfront.
READ STORY >>
|
|
|
HALFTIME ARCADE SHOWDOWN
|
|
|
ONE MORE ROUND IN THE HEALTH MANIA ARENA!
ARCADE CUTSCENE // CONTINUE?
|
|
|
CANCER TRIAL UPSET // OCT 13
BIONTECH'S mRNA CANCER DRUG MISSES A KEY GOAL
A closely watched head-and-neck cancer trial failed its first major
target: delaying disease progression. BioNTech is continuing the
study to see whether its experimental therapy improves overall
survival.
READ STORY >>
|
|
|
STARTUP SMACKDOWN // OCT 14
ZOCDOC MAKES ITS FIRST-EVER ACQUISITION
After nearly 20 years, Zocdoc bought Sohar Health to make insurance
checks less painful when booking care. A real-world health-tech
power move β financial terms were not disclosed.
READ STORY >>
|
|
|
FINAL BELL π₯
Who wins this week's championship belt? Hit reply with your pick β
and send this edition to your favorite health-news fanatic.
|
|
|
HEALTH MANIA // NO FLUFF. ALL FIRE.
|
|